ALPINE / USDT

ALPINE / TRY

FIS / USDT

FIS / BTC

ADX / USDT

REI / USDT

1MBABYDOGE / FDUSD

ADX / ETH

ADX / BTC

HIVE / FDUSD

MDT / USDT

FUN / USDT

MBOX / TRY

D / TRY

MBOX / USDT

D / USDT

SKL / BTC

MAV / BTC

FIO / USDT

ASTR / BTC

AKI INDIA LIMITED

MONOLITHISCH INDIA LTD

ALOK INDUSTRIES LIMITED

AIMTRON ELECTRONICS LTD

CAPITAL TRUST LTD

NDL VENTURES LIMITED

MSP STEEL & POWER LTD.

HARIOM PIPE INDUSTRIES L

SONATA SOFTWARE LTD

IDEAL TECHNOPLAST IND LTD

NECTAR LIFESCIENCES LTD.

NET AVENUE TECHNOLOGIES L

DURLAX TOP SURFACE LTD

SHARDA MOTOR INDS LTD

COOL CAPS INDUSTRIES LTD

PC JEWELLER LTD

NEPHRO CARE INDIA LIMITED

TITAN COMPANY LIMITED

SUBROS LIMITED

DREAMFOLKS SERVICES LTD

Click here to get full coverage on Glenmark Pharmaceuticals Introduces Tevimbra for Advanced Lung and Esophageal Cancers in India - geneonline.com

Glenmark Pharmaceuticals Introduces Tevimbra for Advanced Lung and Esophageal Cancers in India  geneonline.com

Glenmark Pharmaceuticals Introduces Tevimbra for Advanced Lung and Esophageal Cancers in India - geneonline.com

Click here to get full coverage on An Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients - ProPublica

An Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients  ProPublica

An Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients - ProPublica

Click here to get full coverage on Glenmark Pharma stock hits all-time high in early session, trading up 1.1% - TradingView

Glenmark Pharma stock hits all-time high in early session, trading up 1.1%  TradingView

Glenmark Pharma stock hits all-time high in early session, trading up 1.1% - TradingView

Click here to get full coverage on Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) - PR Newswire

Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)  PR Newswire

Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) - PR Newswire

Click here to get full coverage on The Indian pharma market grew 8% in June 2025, led by strong performances from Sun Pharma, Glenmark, Ipca Labs, JB Chemicals & more. Alkem’s PAN was the top-selling brand at ₹71 Cr. Ekta Batra shares more details #Pharma #Growth #CNBCTV18Dig - LinkedIn

The Indian pharma market grew 8% in June 2025, led by strong performances from Sun Pharma, Glenmark, Ipca Labs, JB Chemicals & more. Alkem’s PAN was the top-selling brand at ₹71 Cr. Ekta Batra shares more details #Pharma #Growth #CNBCTV18Dig  LinkedIn

The Indian pharma market grew 8% in June 2025, led by strong performances from Sun Pharma, Glenmark, Ipca Labs, JB Chemicals & more. Alkem’s PAN was the top-selling brand at ₹71 Cr. Ekta Batra shares more details #Pharma #Growth #CNBCTV18Dig - LinkedIn

Click here to get full coverage on Glenmark launches olopatadine HCl 0.2% to US market - Eyes On Eyecare

Glenmark launches olopatadine HCl 0.2% to US market  Eyes On Eyecare

Glenmark launches olopatadine HCl 0.2% to US market - Eyes On Eyecare

Click here to get full coverage on Glenmark gets five observations from USFDA for Monroe plant - The Economic Times

Glenmark gets five observations from USFDA for Monroe plant  The Economic Times

Glenmark gets five observations from USFDA for Monroe plant - The Economic Times

Click here to get full coverage on Glenmark Pharmaceuticals Ltd spurts 1.6%, rises for fifth straight session - Business Standard

Glenmark Pharmaceuticals Ltd spurts 1.6%, rises for fifth straight session  Business Standard

Glenmark Pharmaceuticals Ltd spurts 1.6%, rises for fifth straight session - Business Standard

Click here to get full coverage on AstraZeneca refused interim injunction on SPC for blockbuster diabetes treatment against Glenmark but swiftly obtains permission to appeal - A&O Shearman

AstraZeneca refused interim injunction on SPC for blockbuster diabetes treatment against Glenmark but swiftly obtains permission to appeal  A&O Shearman

AstraZeneca refused interim injunction on SPC for blockbuster diabetes treatment against Glenmark but swiftly obtains permission to appeal - A&O Shearman

Click here to get full coverage on Nearly 1.5 Million Bottles of Glenmark's ADHD Drug Atomoxetine Recalled - MedCentral

Nearly 1.5 Million Bottles of Glenmark's ADHD Drug Atomoxetine Recalled  MedCentral

Nearly 1.5 Million Bottles of Glenmark's ADHD Drug Atomoxetine Recalled - MedCentral

Click here to get full coverage on Nationwide Recall Hits Dozens of Common Generic Drugs—What You Need to Know - health.com

Nationwide Recall Hits Dozens of Common Generic Drugs—What You Need to Know  health.com

Nationwide Recall Hits Dozens of Common Generic Drugs—What You Need to Know - health.com

Click here to get full coverage on Glenmark issues another recall, this time for nearly 1.5M bottles of generic ADHD drug - Fierce Pharma

Glenmark issues another recall, this time for nearly 1.5M bottles of generic ADHD drug  Fierce Pharma

Glenmark issues another recall, this time for nearly 1.5M bottles of generic ADHD drug - Fierce Pharma

Click here to get full coverage on The FDA Finally Visited an Indian Drug Factory Linked to U.S. Deaths. It Found Problems. - ProPublica

The FDA Finally Visited an Indian Drug Factory Linked to U.S. Deaths. It Found Problems.  ProPublica

The FDA Finally Visited an Indian Drug Factory Linked to U.S. Deaths. It Found Problems. - ProPublica

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 10 mg, 15 mg, 20 mg and 30 - PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 10 mg, 15 mg, 20 mg and 30  PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 10 mg, 15 mg, 20 mg and 30 - PR Newswire

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials - PR Newswire

Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials  PR Newswire

Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials - PR Newswire

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial - PR Newswire

Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial  PR Newswire

Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial - PR Newswire

Click here to get full coverage on Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) - PR Newswire

Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)  PR Newswire

Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) - PR Newswire

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial) - PR Newswire

Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial)  PR Newswire

Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial) - PR Newswire

Click here to get full coverage on Glenmark Launches a Transformative Nutrition and Livelihood Project in Emali, Kenya - PR Newswire

Glenmark Launches a Transformative Nutrition and Livelihood Project in Emali, Kenya  PR Newswire

Glenmark Launches a Transformative Nutrition and Livelihood Project in Emali, Kenya - PR Newswire

Click here to get full coverage on Glenmark Therapeutics Inc., USA launches Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC) - PR Newswire

Glenmark Therapeutics Inc., USA launches Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC)  PR Newswire

Glenmark Therapeutics Inc., USA launches Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC) - PR Newswire

Click here to get full coverage on The FDA Hasn’t Inspected This Drug Factory After 7 Recalls for the Same Flaw, 1 Potentially Deadly - ProPublica

The FDA Hasn’t Inspected This Drug Factory After 7 Recalls for the Same Flaw, 1 Potentially Deadly  ProPublica

The FDA Hasn’t Inspected This Drug Factory After 7 Recalls for the Same Flaw, 1 Potentially Deadly - ProPublica

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA launches Clindamycin Phosphate Foam, 1% - PR Newswire

Glenmark Pharmaceuticals Inc., USA launches Clindamycin Phosphate Foam, 1%  PR Newswire

Glenmark Pharmaceuticals Inc., USA launches Clindamycin Phosphate Foam, 1% - PR Newswire

Click here to get full coverage on Glenmark pharma's US facility receives five observations after USFDA GMP inspection - Business Standard

Glenmark pharma's US facility receives five observations after USFDA GMP inspection  Business Standard

Glenmark pharma's US facility receives five observations after USFDA GMP inspection - Business Standard

Click here to get full coverage on No damages for Glenmark in battle over Mundipharma’s Targin - JUVE Patent

No damages for Glenmark in battle over Mundipharma’s Targin  JUVE Patent

No damages for Glenmark in battle over Mundipharma’s Targin - JUVE Patent

Click here to get full coverage on GLENMARK Outlook for the Week (July 07, 2025 – July 11, 2025) - Equitypandit

GLENMARK Outlook for the Week (July 07, 2025 – July 11, 2025)  Equitypandit

GLENMARK Outlook for the Week (July 07, 2025 – July 11, 2025) - Equitypandit

Click here to get full coverage on Ichnos Glenmark Innovation (IGI) Receives U.S. FDA Fast - GlobeNewswire

Ichnos Glenmark Innovation (IGI) Receives U.S. FDA Fast  GlobeNewswire

Ichnos Glenmark Innovation (IGI) Receives U.S. FDA Fast - GlobeNewswire

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA launches Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL) - PR Newswire

Glenmark Pharmaceuticals Inc., USA launches Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL)  PR Newswire

Glenmark Pharmaceuticals Inc., USA launches Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL) - PR Newswire

Click here to get full coverage on Trio of Indian drugmakers issue recalls tied to impurity, labeling issues - Fierce Pharma

Trio of Indian drugmakers issue recalls tied to impurity, labeling issues  Fierce Pharma

Trio of Indian drugmakers issue recalls tied to impurity, labeling issues - Fierce Pharma

Click here to get full coverage on Glenmark Eyes Generic Flovent Launch In Coming Months Amid Expected US Resurgence - insights.citeline.com

Glenmark Eyes Generic Flovent Launch In Coming Months Amid Expected US Resurgence  insights.citeline.com

Glenmark Eyes Generic Flovent Launch In Coming Months Amid Expected US Resurgence - insights.citeline.com

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA launches Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules - PR Newswire

Glenmark Pharmaceuticals Inc., USA launches Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules  PR Newswire

Glenmark Pharmaceuticals Inc., USA launches Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules - PR Newswire

Click here to get full coverage on Glenmark Pharmaceuticals Ltd up for third straight session - Business Standard

Glenmark Pharmaceuticals Ltd up for third straight session  Business Standard

Glenmark Pharmaceuticals Ltd up for third straight session - Business Standard

Click here to get full coverage on UK Court of Appeal blocks Glenmark’s diabetes generic - JUVE Patent

UK Court of Appeal blocks Glenmark’s diabetes generic  JUVE Patent

UK Court of Appeal blocks Glenmark’s diabetes generic - JUVE Patent

Click here to get full coverage on 100% of users reported hair growth in 12 weeks: Glenmark | 100% users saw hair growth by week 12: Glenmark | Inshorts - Inshorts

100% of users reported hair growth in 12 weeks: Glenmark | 100% users saw hair growth by week 12: Glenmark | Inshorts  Inshorts

100% of users reported hair growth in 12 weeks: Glenmark | 100% users saw hair growth by week 12: Glenmark | Inshorts - Inshorts

Click here to get full coverage on Glenmark to launch cancer drug Zanubrutinib in India - Mint

Glenmark to launch cancer drug Zanubrutinib in India  Mint

Glenmark to launch cancer drug Zanubrutinib in India - Mint

Click here to get full coverage on Glenmark recalls 15 lakh bottles of ADHD medication in US: USFDA - The Economic Times

Glenmark recalls 15 lakh bottles of ADHD medication in US: USFDA  The Economic Times

Glenmark recalls 15 lakh bottles of ADHD medication in US: USFDA - The Economic Times

Click here to get full coverage on Chartist Talks: Sudeep Shah of SBI Securities explains why he is bullish on these 6 stocks but flags... - Moneycontrol

Chartist Talks: Sudeep Shah of SBI Securities explains why he is bullish on these 6 stocks but flags...  Moneycontrol

Chartist Talks: Sudeep Shah of SBI Securities explains why he is bullish on these 6 stocks but flags... - Moneycontrol

Click here to get full coverage on Glenmark Pharma's Monroe facility in North America gets five USFDA observations - CNBC TV18

Glenmark Pharma's Monroe facility in North America gets five USFDA observations  CNBC TV18

Glenmark Pharma's Monroe facility in North America gets five USFDA observations - CNBC TV18

Click here to get full coverage on HDFC Mutual Fund raises stake in Glenmark Pharmaceuticals to 5.07%. Details here - Mint

HDFC Mutual Fund raises stake in Glenmark Pharmaceuticals to 5.07%. Details here  Mint

HDFC Mutual Fund raises stake in Glenmark Pharmaceuticals to 5.07%. Details here - Mint

Click here to get full coverage on Glenmark Adamant FDA Monroe Site Reinspection Could Happen ‘Any Time’ - insights.citeline.com

Glenmark Adamant FDA Monroe Site Reinspection Could Happen ‘Any Time’  insights.citeline.com

Glenmark Adamant FDA Monroe Site Reinspection Could Happen ‘Any Time’ - insights.citeline.com

Click here to get full coverage on Glenmark to launch DCGI-approved cancer drug in India - The Economic Times

Glenmark to launch DCGI-approved cancer drug in India  The Economic Times

Glenmark to launch DCGI-approved cancer drug in India - The Economic Times

Click here to get full coverage on Glenmark Pharma shares up 2% after FDA grants fast track status to cancer drug - The Economic Times

Glenmark Pharma shares up 2% after FDA grants fast track status to cancer drug  The Economic Times

Glenmark Pharma shares up 2% after FDA grants fast track status to cancer drug - The Economic Times

Click here to get full coverage on Glenmark Pharma: FDA concludes inspection at US facility, issues five observations - financialexpress.com

Glenmark Pharma: FDA concludes inspection at US facility, issues five observations  financialexpress.com

Glenmark Pharma: FDA concludes inspection at US facility, issues five observations - financialexpress.com

Click here to get full coverage on 15 Lakh Bottles Of ADHD Medication Recalled In U.S. By Glenmark - NDTV

15 Lakh Bottles Of ADHD Medication Recalled In U.S. By Glenmark  NDTV

15 Lakh Bottles Of ADHD Medication Recalled In U.S. By Glenmark - NDTV

Click here to get full coverage on Ichnos Glenmark Innovation (IGI) Presents First Clinical Data from Phase 1 Study of Trispecific TREAT™ Antibody, ISB 2001, Showing High Overall Response Rate (ORR) with Durable Responses and Favorable Safety Profile in Patients with Heavily Pretreate - GlobeNewswire

Ichnos Glenmark Innovation (IGI) Presents First Clinical Data from Phase 1 Study of Trispecific TREAT™ Antibody, ISB 2001, Showing High Overall Response Rate (ORR) with Durable Responses and Favorable Safety Profile in Patients with Heavily Pretreate  GlobeNewswire

Ichnos Glenmark Innovation (IGI) Presents First Clinical Data from Phase 1 Study of Trispecific TREAT™ Antibody, ISB 2001, Showing High Overall Response Rate (ORR) with Durable Responses and Favorable Safety Profile in Patients with Heavily Pretreate - GlobeNewswire

Click here to get full coverage on Glenmark shares crash 6% after USFDA order discloses 39 drugs recalled from US market - Moneycontrol

Glenmark shares crash 6% after USFDA order discloses 39 drugs recalled from US market  Moneycontrol

Glenmark shares crash 6% after USFDA order discloses 39 drugs recalled from US market - Moneycontrol

Click here to get full coverage on Glenmark joins growing list of drugmakers to settle long-running US price-fixing claims - Fierce Pharma

Glenmark joins growing list of drugmakers to settle long-running US price-fixing claims  Fierce Pharma

Glenmark joins growing list of drugmakers to settle long-running US price-fixing claims - Fierce Pharma

Click here to get full coverage on Glenmark’s myeloma drug delivers high response in phase-1 trial - Moneycontrol

Glenmark’s myeloma drug delivers high response in phase-1 trial  Moneycontrol

Glenmark’s myeloma drug delivers high response in phase-1 trial - Moneycontrol

Click here to get full coverage on Glenmark: USFDA Issues 5 Procedural Observations for Monroe Unit - Moneycontrol

Glenmark: USFDA Issues 5 Procedural Observations for Monroe Unit  Moneycontrol

Glenmark: USFDA Issues 5 Procedural Observations for Monroe Unit - Moneycontrol

Click here to get full coverage on Glenmark's cancer drug shows strong results in early trial for Myeloma - Business Standard

Glenmark's cancer drug shows strong results in early trial for Myeloma  Business Standard

Glenmark's cancer drug shows strong results in early trial for Myeloma - Business Standard

Click here to get full coverage on CDSCO Panel Asks Glenmark To Justify BE Waiver for FDC Inhalation Suspension With Scientific Evidence - Medical Dialogues

CDSCO Panel Asks Glenmark To Justify BE Waiver for FDC Inhalation Suspension With Scientific Evidence  Medical Dialogues

CDSCO Panel Asks Glenmark To Justify BE Waiver for FDC Inhalation Suspension With Scientific Evidence - Medical Dialogues

Click here to get full coverage on Generic Drugs Recalled Due to Quality Issues - AARP

Generic Drugs Recalled Due to Quality Issues  AARP

Generic Drugs Recalled Due to Quality Issues - AARP

Click here to get full coverage on Glenmark’s technical breakout signals rally ahead: Religare’s Ajit Mishra - The Economic Times

Glenmark’s technical breakout signals rally ahead: Religare’s Ajit Mishra  The Economic Times

Glenmark’s technical breakout signals rally ahead: Religare’s Ajit Mishra - The Economic Times

Click here to get full coverage on Glenmark USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets - Business Standard

Glenmark USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets  Business Standard

Glenmark USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets - Business Standard

Click here to get full coverage on Glenmark Pharma's US arm set to launch generic Adderall tablets - Business Standard

Glenmark Pharma's US arm set to launch generic Adderall tablets  Business Standard

Glenmark Pharmaceuticals Limited (GLENMARK)

Price Chart

Key Statistics

Technicals

About GLENMARK

Latest News

Glenmark Pharmaceuticals Introduces Tevimbra for Advanced Lung and Esophageal Cancers in India - geneonline.com

An Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients - ProPublica

Glenmark Pharma stock hits all-time high in early session, trading up 1.1% - TradingView

Advanced Charts

Top Gainers

Top Losers